Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study
Pablo Ureña, Stefan H Jacobson, Emanuel Zitt, Marc Vervloet, Fabio Malberti, Neil Ashman, Sean Leavey, Marianne Rix, Ingrid Os, Heikki Saha, Miroslav Ryba, Veronika Bencova, Ana Baños, Valter Zani, Denis Fouque
DOI: 10.1093/ndt/gfp144
Klíčová slova: Adult, Aged, Bone and Bones, Calcium, Europe, Female, Humans, Hyperparathyroidism, Secondary, Kidney Failure, Chronic, Male, Middle Aged, Minerals, Naphthalenes, Parathyroid Hormone, Phosphorus, Renal Dialysis, Vitamin D
Anotace:
BACKGROUND: The use and effectiveness of cinacalcet in 'real-world' clinical practice was investigated in a pan-European observational study in dialysis patients with secondary hyperparathyroidism (SHPT) of varying severity. BACKGROUND: The use and effectiveness of cinacalcet in 'real-world' clinical practice was investigated in a pan-European observational study in dialysis patients with secondary hyperparathyroidism (SHPT) of varying severity. BACKGROUND: The use and effectiveness of cinacalcet in 'real-world' clinical practice was investigated in a pan-European observational study in dialysis patients with secondary hyperparathyroidism (SHPT) of varying severity. BACKGROUND: The use and effectiveness of cinacalcet in 'real-world' clinical practice was investigated in a pan-European observational study in dialysis patients with secondary hyperparathyroidism (SHPT) of varying severity.